Progetti FP7 coordinati da "Karolinska institutet"
| # | ||||
|---|---|---|---|---|
| 1 | SPINAL CORD REPAIR Spinal locomotor circuits: organization and repair after injury | 2008 | 3˙935˙200.00 | 2˙998˙000.00 |
| 2 | APO-SYS "Apoptosis systems biology applied to cancer and AIDS. An integrated approach of experimental biology, data mining, mathematical modelling, biostatistics, systems engineering and molecular medicine" | 2008 | 14˙780˙447.00 | 11˙000˙000.00 |
| 3 | LACTOBODY Production and delivery of antibody fragments against gastrointestinal pathogens by lactobacilli | 2008 | 5˙555˙220.00 | 3˙988˙019.00 |
| 4 | GENTRECAD "GENOME-WIDE CHARACTERIZATION OF TRANSCRIPTIONAL REGULATORY ELEMENTS, PATHWAYS AND ASSOCIATED GENETIC VARIATIONS INVOLVED IN THE PATHOGENESIS OF CORONARY ARTERY DISEASE" | 2008 | 170˙697.00 | 170˙697.00 |
| 5 | EUCAAD European Consortium for Anticancer Antibody Development | 2008 | 7˙862˙359.00 | 5˙989˙862.00 |
| 6 | SME RECEPTOR SME-Academia Nuclear Receptor Knowledge Transfer | 2008 | 1˙659˙159.00 | 1˙659˙159.00 |
| 7 | APO-HSV-2/HIV Double infection by HSV-2 and HIV: how does HSV-2 infection facilitate for HIV infection? | 2008 | 232˙646.00 | 232˙646.00 |
| 8 | SELECT-AND-ACT "The role of striatum in selection of behaviour and motor learning - neuronal code, microcircuits and modelling" | 2008 | 3˙253˙587.00 | 2˙495˙781.00 |
| 9 | GIFT Graft engineering to improve allogeneic stem cell transplantation | 2008 | 179˙588.00 | 179˙588.00 |
| 10 | INFLAMMATIONPAIN Role of spinal anti-inflammatory lipid mediators in inflammation and arthritis-induced pain | 2008 | 100˙000.00 | 100˙000.00 |
| 11 | NANOMMUNE Comprehensive assessment of hazardous effects of engineered nanomaterials on the immune system | 2008 | 4˙310˙500.00 | 3˙358˙500.00 |
| 12 | GENOMIC STABILITY Genomic stability -chromosome segregation and repair | 2008 | 900˙000.00 | 900˙000.00 |
| 13 | NEOOPIOID No Pain during infancy by adapting off-patent medicines | 2008 | 2˙881˙489.00 | 2˙299˙164.00 |
| 14 | HOMITB Host and microbial molecular dissection of pathogenesis and immunity in tuberculosis | 2008 | 3˙931˙510.00 | 2˙998˙251.00 |
| 15 | HIVIND The antiretroviral roll out for HIV in India - strengthening capacity to promote adherence and patient follow-up in the context | 2008 | 3˙881˙494.00 | 2˙946˙420.00 |
| 16 | INCOMB "Combating incontinence, from basic science to clinical practice" | 2008 | 4˙035˙977.00 | 2˙908˙693.00 |
| 17 | BODY-OWNERSHIP Neural mechanisms of body ownership and the projection of ownership onto artificial bodies | 2008 | 909˙850.00 | 909˙850.00 |
| 18 | EURO-GENE-SCAN European Genetic Disease Diagnostics | 2009 | 3˙822˙299.00 | 2˙913˙807.00 |
| 19 | INUTERAL Influence of the in utero environment on the risk of allergy development for the child | 2009 | 177˙887.00 | 177˙887.00 |
| 20 | ICEBERG Discovery of Type 2 Diabetes Targets | 2009 | 2˙500˙000.00 | 2˙500˙000.00 |
| 21 | NKT IN HERPES The role of natural killer T cells in the early stages of the herpes simplex virus infection in skin | 2009 | 179˙588.00 | 179˙588.00 |
| 22 | MIGBTB Molecular mechanisms of germ cell migration across the mammalian blood-testis barrier | 2009 | 242˙672.00 | 242˙672.00 |
| 23 | SEYLE Saving and Empowering Young Lives in Europe: Promote health through prevention of risk-taking and self-destructive behaviors | 2009 | 4˙781˙263.00 | 2˙983˙941.00 |
| 24 | SENSORY NEURONS CODE Defining the transcription factors code directing sensory lineage diversification and connectivity | 2009 | 178˙454.00 | 178˙454.00 |
| 25 | STEMRENEWAL Identification of a new mechanism of stem cell self-renewal; direct implications on self-repair and tumor initiating cells in the brain | 2009 | 2˙492˙593.00 | 2˙492˙593.00 |
| 26 | GROWTHCONTROL Dissecting the transcriptional mechanisms controlling growth during normal development and cancer | 2009 | 2˙200˙000.00 | 2˙200˙000.00 |
| 27 | ALK7 Metabolic control by the TGF-² superfamily receptor ALK7: A novel regulator of insulin secretion, fat accumulation and energy balance | 2009 | 2˙462˙154.00 | 2˙462˙154.00 |
| 28 | COGS Collaborative Oncological Gene-environment Study | 2009 | 16˙703˙903.00 | 11˙715˙501.00 |
| 29 | MAMMAHOGLGR Understanding Hedgehog signalling in breast cancer and mammary gland stem cells using tissue specific expression of Gli1 the main effector of the Hedgehog pathway | 2009 | 179˙223.00 | 179˙223.00 |
| 30 | AISAT Development of a new high throughput automated imaging system to carry out drug sensitivity measurements on primary leukemia/lymphoma cells to assist individualized assay guided therapy | 2009 | 178˙089.00 | 178˙089.00 |
| 31 | MCI_AD PIB-PET_FMRI Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer’s disease: Relating the Impact of Amyloid Burden with PIB-PET on Neuronal Activation as Assessed with fMRI | 2009 | 221˙369.00 | 221˙369.00 |
| 32 | TORNADO Molecular Targets Open for Regulation by the gut flora – New Avenues for improved Diet to Optimize European health | 2009 | 7˙771˙046.00 | 5˙895˙601.00 |
| 33 | TREG SUPPRESSION Deciphering the molecular basis of regulatory T cell suppression | 2009 | 100˙000.00 | 100˙000.00 |
| 34 | CHEMO-IMMUNE THERAPY A translational approach evaluating novel strategies using chemotherapy to enhance immune-mediated anti-tumor activity | 2009 | 100˙000.00 | 100˙000.00 |
| 35 | IMMUNOSWITCH Switch recombination: a model system for DNA editing and repair in human lymphocytes with relevance for primary immunodeficiency and cancer formation | 2009 | 1˙888˙166.00 | 1˙888˙166.00 |
| 36 | DC-MTB INTERACTIONS Visualization of Dendritic cell IL-12 production and engagement with antigen-specific T cells during Mycobacterium tuberculosis infection in vivo | 2010 | 100˙000.00 | 100˙000.00 |
| 37 | 3DMIG Use of high resolution imaging to elucidate cell migration dynamics within 3D environments | 2010 | 0.00 | 173˙167.00 |
| 38 | SINGLE-CELL GENOMICS Single-cell Gene Regulation in Differentiation and Pluripotency | 2010 | 1˙654˙383.00 | 1˙654˙383.00 |
| 39 | ISSC An integrated surveillance system for infectious disease in rural China: generating evidence for early detection of disease epidemics in resource-poor settings | 2010 | 3˙898˙390.00 | 2˙967˙837.00 |
| 40 | ANGIOFAT New mechanisms of angiogenesis modulators in switching between white and brown adipose tissues | 2010 | 2˙411˙547.00 | 2˙411˙547.00 |
| 41 | IGF1RHC Targeting IGF-1 receptor in liver cancer with focus on its mechanistic role in transcription and its interaction with the cell cycle machinery | 2010 | 0.00 | 236˙351.00 |
| 42 | PREVENTRA "Genes, environment and immunity in the pathogenesis of rheumatoid arthritis" | 2010 | 2˙000˙000.00 | 2˙000˙000.00 |
| 43 | WASPSTINGS Unravelling the mechanism for development of WASP-associated primary immunodeficiency | 2010 | 100˙000.00 | 100˙000.00 |
| 44 | TMP53COMPMIX Transcriptional mutagenesis in mammalian cell systems: p53 signaling as a probe of cellular effects | 2010 | 100˙000.00 | 100˙000.00 |
| 45 | WE-STAY Work Toghether to Stop Truancy Among Youth | 2010 | 3˙670˙569.00 | 2˙995˙947.00 |
| 46 | DOPAMINE NEURON CODE Developmental Transcription Factors in Dopamine Neuron Maintenance | 2010 | 180˙669.00 | 180˙669.00 |
| 47 | INDEFIC Identification of New Genetic Determinants of Plasma Fibrinogen Concentration | 2010 | 181˙669.00 | 181˙669.00 |
| 48 | FERFLU EXPRESS Investigation of influenza immune responses and vaccine efficacy correlates by global expression profiling and immunological analyses in the ferret model of influenza | 2010 | 239˙693.00 | 239˙693.00 |
| 49 | DKK3 T2DM Wnt agonist Dickkopf 3 (DKK3) is a type 2 diabetes susceptibility gene | 2010 | 75˙000.00 | 75˙000.00 |
| 50 | EQUIP Expanded Quality management Using Information Power for Maternal and Newborn Health in Africa | 2010 | 3˙885˙475.00 | 2˙998˙406.00 |
| 51 | NK IN HLH Molecular mechanisms of pediatric immunodeficiency syndromes affecting natural killer cell cytotoxicity | 2010 | 181˙669.00 | 181˙669.00 |
| 52 | SYSCOL Systems Biology of Colorectal Cancer | 2011 | 16˙615˙047.00 | 11˙999˙996.00 |
| 53 | SYSTEMS MICROSCOPY Systems microscopy – a key enabling methodology for next-generation systems biology | 2011 | 15˙964˙673.00 | 11˙986˙690.00 |
| 54 | EUROCANPLATFORM A European Platform for Translational Cancer Research | 2011 | 15˙561˙005.00 | 11˙998˙454.00 |
| 55 | GAMETE RECOGNITION Molecular Basis of Mammalian Egg-Sperm Interaction | 2011 | 1˙499˙281.00 | 1˙499˙281.00 |
| 56 | ENDOSWITCH Network Principles of Neuroendocrine Control: Tuberoinfundibular Dopamine (TIDA) Oscillations and the Regulation of Lactation | 2011 | 1˙493˙958.00 | 1˙493˙958.00 |
| 57 | CANCERTIME The biological clock and cancer | 2011 | 250˙773.00 | 250˙773.00 |
| 58 | GENECADD GEnetic NEtworks as a tool for anti-CAncer Drug Development | 2011 | 2˙500˙000.00 | 2˙500˙000.00 |
| 59 | OPTO-REW Optogenetic investigation of GABAergic interneurons in the limbic system during reward and addiction | 2011 | 100˙000.00 | 100˙000.00 |
| 60 | CASCADE-FELLOWS The CASCADE International Fellowship Programme | 2011 | 12˙482˙120.00 | 4˙992˙848.00 |
| 61 | HUFATREG Adipose tissue mass regulation in lean and obese individuals | 2011 | 1˙500˙000.00 | 1˙500˙000.00 |
| 62 | ARCADE HSSR African Regional Capacity Development for Health Systems and Services Research | 2011 | 2˙193˙184.00 | 1˙978˙424.00 |
| 63 | MATIND Large scale innovative pro-poor programs focused on reducing maternal mortality in India: a proposal for impact evaluation | 2011 | 3˙905˙283.00 | 2˙969˙172.00 |
| 64 | TRANSLATOMICS Painting the landscape of translational control of gene expression through meta-analysis of genome wide data sets | 2011 | 100˙000.00 | 100˙000.00 |
| 65 | NEURAL RENEWAL Neurogenesis in the adult human brain | 2011 | 2˙491˙235.00 | 2˙491˙235.00 |
| 66 | CAFTECH Unraveling the therapeutic potential of cancer-associated fibroblasts (CAF) in cancer using cell-specific targeting technology | 2011 | 50˙000.00 | 50˙000.00 |
| 67 | COMMHERE Communication of European Health Research | 2011 | 2˙249˙134.00 | 1˙998˙441.00 |
| 68 | HUMAN IPS IN SCI Human iPS cell therapy for spinal cord injury | 2011 | 194˙766.00 | 194˙766.00 |
| 69 | ARCADE RSDH Asian Regional Capacity Development for Research on Social Determinants of Health | 2011 | 2˙201˙583.00 | 1˙996˙595.00 |
| 70 | VTHAND-CENTRED SPACE Visuo-tactile cortical mechanims for a hand-centred spatial representation in humans | 2011 | 186˙464.00 | 186˙464.00 |
| 71 | META-PREDICT Developing predictors of the health benefits of exercise for individuals | 2011 | 7˙928˙818.00 | 5˙998˙406.00 |
| 72 | DDPDGENES Identification of genes important for human midbrain dopamine neuron development and Parkinson’s disease | 2012 | 3˙700˙382.00 | 2˙817˙939.00 |
| 73 | AGING STEM CELLS Mechanisms of stem cell proliferation and senescence in the aged and damaged mouse brain | 2012 | 195˙766.00 | 195˙766.00 |
| 74 | BRAINGAIN NOVEL STRATEGIES FOR BRAIN REGENERATION | 2012 | 1˙500˙000.00 | 1˙500˙000.00 |
| 75 | SENSTRIATUM Sensory Integration in the Striatal Microcircuit | 2012 | 1˙494˙445.00 | 1˙494˙445.00 |
| 76 | BIOTRACHEA Biomaterials for Tracheal Replacement in Age-related Cancer via a Humanly Engineered Airway | 2012 | 5˙464˙792.00 | 3˙999˙300.00 |
| 77 | STAGED "Stress and the aging brain: the interplay between genetic susceptibility, aging and psychosocial stress on early symptoms of dementia" | 2012 | 136˙063.00 | 136˙063.00 |
| 78 | GENOMIC INTERACTIONS B-cell development and gene regulation in three dimensions | 2012 | 100˙000.00 | 100˙000.00 |
| 79 | PRACTICE Prevent Rheumatoid Arthritis in Practice | 2012 | 156˙000.00 | 144˙300.00 |
| 80 | BRAINPROP Brain mechanisms of human limb movement sense | 2012 | 174˙016.00 | 174˙016.00 |
| 81 | MOLMECHSNKTOX Molecular Mechanisms of Natural Killer cell Cytotoxicity | 2012 | 181˙418.00 | 181˙418.00 |
| 82 | MUSC ADAP XRCS Mechanisms of skeletal muscle adaptation to exercise and their implications in health and disease | 2012 | 100˙000.00 | 100˙000.00 |
| 83 | DARMEC Drug adverse reactions predictability: exploring the mechanisms underlying the unexplained interindividual differences in drug metabolism and transport | 2012 | 100˙000.00 | 100˙000.00 |
| 84 | ADOLESCENT DEV Genetics and physiology of adolescent development in telencephalic interneurons | 2012 | 100˙000.00 | 100˙000.00 |
| 85 | ELSI Emotional Learning in Social Interaction | 2012 | 1˙498˙243.00 | 1˙498˙243.00 |
| 86 | LGR6MAMMARYSC The role of Lgr6 as a marker of progenitor cells and cancer-initiating cells in the mammary gland | 2013 | 181˙418.00 | 181˙418.00 |
| 87 | INFECT Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures that Dictate Severity of Tissue Infection | 2013 | 15˙678˙988.00 | 11˙913˙591.00 |
| 88 | NOVEL_MYOKINE Irisin - a novel myokine protective against metabolic disease | 2013 | 1˙999˙433.00 | 1˙999˙433.00 |
| 89 | PERICYTESCAR The role of pericytes in central nervous system scarring and fibrosis | 2013 | 1˙750˙000.00 | 1˙750˙000.00 |
| 90 | EPIOPC Role of chromatin-modifying enzymes in oligodendrocyte precursor state in development and multiple sclerosis | 2013 | 100˙000.00 | 100˙000.00 |
| 91 | MEMORYSTICK Plasticity and formation of lasting memories in health and disease. Genetic modeling of key regulators in adult and aging mammals and in neurodegenerative disease | 2013 | 2˙330˙974.00 | 2˙330˙974.00 |
| 92 | SEQ-CYTOTOX Next generation sequencing for detection of human primary immunodeficiency syndromes characterized by impaired cytotoxic lymphocyte function | 2013 | 1˙499˙996.00 | 1˙499˙996.00 |
| 93 | OBINNSC1 The Physiological Control of Stem Cells: Obesity, Insulin, and Neural Stem Cell Dynamics | 2013 | 181˙418.00 | 181˙418.00 |
| 94 | SIZE MATTERS Size Matters: investigating the link between affective and perceptual body representations using multisensory illusions and brain imaging | 2013 | 206˙350.00 | 206˙350.00 |
| 95 | F12 Factor XII and the contact system: cross-talk between thrombosis and inflammation | 2013 | 1˙488˙780.00 | 1˙488˙780.00 |
| 96 | NCAT Nudix hydrolases in Cancer Therapy | 2013 | 197˙811.00 | 197˙811.00 |
| 97 | IMPLEMENT A research agenda on implementation research in chronic care | 2013 | 549˙835.00 | 500˙000.00 |
| 98 | AD BIOMARKERS Combining sensitive biomarkers for early diagnosis of AD: A multi-modal approach | 2013 | 197˙811.00 | 197˙811.00 |
| 99 | HUMAN "Health and the Understanding of Metabolism, Aging and Nutrition" | 2013 | 16˙155˙448.00 | 11˙994˙553.00 |
| 100 | COUNTERSTROKE Treating stroke with Affibody molecules targeting the inflammatory mediator HMGB1 | 2013 | 7˙843˙758.00 | 5˙989˙631.00 |
| 101 | ITREGDIFFERENTIATION Kinetic analysis of molecular profiles during human induced regulatory T cell (iTreg) differentiation: an integrative study | 2014 | 197˙811.00 | 197˙811.00 |
| 102 | NEURODYNAMICS Inhibition and neuromodulation in oscillation and synchrony | 2014 | 275˙138.00 | 275˙138.00 |
| 103 | COGOPTO The role of parvalbumin interneurons in cognition and behavior | 2014 | 1˙400˙000.00 | 1˙400˙000.00 |
| 104 | BETAIMAGE An in vivo imaging approach to understand pancreatic beta-cell signal-transduction | 2014 | 2˙499˙590.00 | 2˙499˙590.00 |
| 105 | POCUMINT Proof Of Concept Use of MTH1 Inhibitors as New Treatments for cancer | 2014 | 164˙795.00 | 150˙000.00 |
| 106 | INTERDRUG Epigenetic mechanisms underlying inter-individual differences in drug response and hepatic disease | 2014 | 206˙350.00 | 206˙350.00 |
| 107 | MECHCOMM Mechanotransduction in Cell-to-Cell Communication | 2014 | 2˙292˙100.00 | 2˙292˙100.00 |
| 108 | P75NTR Understanding death-receptor signaling and physiology in the nervous system: A roadmap for the development of new treatments to neurodegenerative diseases and neurotrauma | 2014 | 2˙500˙000.00 | 2˙500˙000.00 |
| 109 | REBOOT Releasing the brakes on adult plasticity | 2014 | 1˙918˙069.00 | 1˙918˙069.00 |
| 110 | DENDRITICDEV Molecular Regulation of Dendritic Tree Formation during Neocortical Development | 2014 | 100˙000.00 | 100˙000.00 |
| 111 | RNASEBGLAND Regulation of gene expression in sebaceous glands | 2015 | 206˙350.00 | 206˙350.00 |
Altri progetti
L'Ente karolinska institutet partecipato anche in questi progetti.
- OH-NEXTGEN (2011, participant)
- CARING (2011, participant)
- COPING (2010, participant)
- ALLBIO (2011, participant)
- MARINA (2011, participant)
- ASC-Inclusion (2011, participant)
- BETATRAIN (2012, participant)
- SENSTRIATUM (2012, hostInstitution)
- SENSTRIATUM (2012, hostInstitution)
- BRAINGAIN (2012, hostInstitution)
- BRAINGAIN (2012, hostInstitution)
- SATIN (2012, participant)
- RAPID (2012, participant)
- INMIND (2012, participant)
- BIOMEDBRIDGES (2012, participant)
- OZMALNET (2012, participant)
- INTREALL (2011, participant)
- RESPONSIFY (2012, participant)
- ECRIN-IA (2012, participant)
- DEMETRIQ (2012, participant)
- IDEA (2012, participant)
- NEURINOX (2012, participant)
- RESTORATION (2012, participant)
- OSTEOIMMUNE (2012, participant)
- NEUEAR (2012, participant)
- AMBULUNG (2012, participant)
- PROHEARING (2012, participant)
- NANOMAL (2012, participant)
- BBBARRIER (2012, beneficiary)
- ELSI (2012, hostInstitution)
- ELSI (2012, hostInstitution)
- PRACTICE (2012, hostInstitution)
- CAFFEIN (2012, participant)
- PATHWAY-27 (2013, participant)
- STATEGRA (2012, participant)
- PROJECT INTEGRATE (2012, participant)
- MOVING BEYOND (2012, participant)
- ESCODNA (2013, participant)
- EURO-TEAM (2012, participant)
- DSD-LIFE (2012, participant)
- HATICE (2013, participant)
- NOVEL_MYOKINE (2013, hostInstitution)
- NOVEL_MYOKINE (2013, hostInstitution)
- RARE-BESTPRACTICES (2013, participant)
- RD-CONNECT (2012, participant)
- PREVENTROP (2012, participant)
- eI4Africa (2012, participant)
- IMPROVED (2012, participant)
- TRIGGER (2013, participant)
- PERICYTESCAR (2013, hostInstitution)
- PERICYTESCAR (2013, hostInstitution)
- CASYM (2012, participant)
- IBD-CHARACTER (2012, participant)
- INFRAFRONTIER-I3 (2013, participant)
- COMBIMS (2013, participant)
- BiobankCloud (2012, participant)
- VESSEL (2013, participant)
- ATTACK (2012, participant)
- SARM (2013, participant)
- NANOSOLUTIONS (2013, participant)
- NANOREG (2013, participant)
- MEMORYSTICK (2013, hostInstitution)
- MEMORYSTICK (2013, hostInstitution)
- SEQ-CYTOTOX (2013, hostInstitution)
- SEQ-CYTOTOX (2013, hostInstitution)
- BBMRI-LPC (2013, participant)
- SUBCOP (2013, participant)
- EARIP (2013, participant)
- ATHERO-FLUX (2013, participant)
- F12 (2013, hostInstitution)
- F12 (2013, hostInstitution)
- CLOSED (2013, participant)
- CARTARDIS (2013, participant)
- MINDVIEW (2013, participant)
- NR-NET (2013, participant)
- WNTSAPP (2013, participant)
- ATHERO-B-CELL (2013, participant)
- LAPASO (2013, participant)
- GRAPHENE (2013, participant)
- EUROCLAST (2013, participant)
- HBP (2013, participant)
- CENTER-TBI (2013, participant)
- EU-CERT-ICD (2013, participant)
- COHEAHR (2013, participant)
- SUN (2013, participant)
- NEUROSTEMCELLREPAIR (2013, participant)
- CAMEI (2013, participant)
- VIA (2013, participant)
- HEALS (2013, participant)
- GLORIA (2013, participant)
- SYNSIGNAL (2013, participant)
- ENANOMAPPER (2014, participant)
- NOROSENSOR (2013, participant)
- SPLENDID (2013, participant)
- BETAIMAGE (2014, hostInstitution)
- BETAIMAGE (2014, hostInstitution)
- ACTION (2014, participant)
- EPIRADBIO (2011, participant)
- P75NTR (2014, hostInstitution)
- P75NTR (2014, hostInstitution)
- GROWSPERM (2014, participant)
- REBOOT (2014, hostInstitution)
- REBOOT (2014, hostInstitution)
- MECHCOMM (2014, hostInstitution)
- MECHCOMM (2014, hostInstitution)
- POCUMINT (2014, hostInstitution)
- CAUSALPATH (2015, beneficiary)
- COGOPTO (2014, hostInstitution)
- COGOPTO (2014, hostInstitution)
- LAMPETRA (2008, participant)
- NEUGRID (2008, participant)
- VPH NoE (2008, participant)
- PredictAD (2008, participant)
- RAREDISEASEPLATFORM (2008, participant)
- FLUODIAMON (2008, participant)
- EDICT (2008, participant)
- CANCERGENE (2008, participant)
- CUREHLH (2008, participant)
- EURO-PADNET (2008, participant)
- INFRAFRONTIER (2008, participant)
- EATRIS (2008, participant)
- PREGVAX (2008, participant)
- TOLERAGE (2008, participant)
- EUSTROKE (2008, participant)
- METAFIGHT (2008, participant)
- GENOMIC STABILITY (2008, hostInstitution)
- GENOMIC STABILITY (2008, hostInstitution)
- GEN2PHEN (2008, participant)
- ETHICSWEB (2008, participant)
- FAD (2008, participant)
- EUROSYSTEM (2008, participant)
- ADAPT (2008, participant)
- MEMOLOAD (2008, participant)
- EURADRENAL (2008, participant)
- ENGAGE (2008, participant)
- NGIN (2008, participant)
- EURODSD (2008, participant)
- ATHEROREMO (2008, participant)
- BBMRI (2008, participant)
- LIPIDIDIET (2008, participant)
- CHILD-MED-RAD (2008, participant)
- NMD-CHIP (2008, participant)
- NEUROSTEMCELL (2008, participant)
- AEROPATH (2008, participant)
- ESCAPE (2008, participant)
- CROSS-TALK (2008, participant)
- PARTNER (2008, participant)
- CHAGASEPINET (2009, participant)
- NOTCHIT (2009, participant)
- BODY-OWNERSHIP (2008, hostInstitution)
- BODY-OWNERSHIP (2008, hostInstitution)
- MDDANEURODEV (2009, participant)
- ICEBERG (2009, hostInstitution)
- ICEBERG (2009, hostInstitution)
- NAD (2008, participant)
- TINN (2008, participant)
- EMMASERVICE (2009, participant)
- MASTERSWITCH (2008, participant)
- HANDOVER (2008, participant)
- FIRE (2009, participant)
- EIMID-IAPP (2008, participant)
- STEMRENEWAL (2009, hostInstitution)
- STEMRENEWAL (2009, hostInstitution)
- GROWTHCONTROL (2009, hostInstitution)
- GROWTHCONTROL (2009, hostInstitution)
- MOLPARK (2009, participant)
- ALK7 (2009, hostInstitution)
- ALK7 (2009, hostInstitution)
- ICONZ (2009, participant)
- SYSTEQ (2009, participant)
- ANCIEN (2009, participant)
- ICEPURE (2009, participant)
- ENRIECO (2009, participant)
- CHAIN (2009, participant)
- PNEUMOPATH (2009, participant)
- METOXIA (2009, participant)
- SURE (2009, participant)
- QUALMAT (2009, participant)
- GRADIENT (2009, participant)
- RN4CAST (2009, participant)
- SAGHE (2009, participant)
- FLAVIOLA (2009, participant)
- VIBRANT (2009, participant)
- PRIORITY (2009, participant)
- SINGLE-CELL GENOMICS (2010, hostInstitution)
- SINGLE-CELL GENOMICS (2010, hostInstitution)
- ENNAH (2009, participant)
- ULICE (2009, participant)
- TRACK_FAST (2009, participant)
- HEALING (2009, participant)
- ANTIRESDEV (2009, participant)
- NEMO (2009, participant)
- CAMBRELLA (2010, participant)
- VIRUS ENTRY (2009, participant)
- IMMUNOSWITCH (2009, hostInstitution)
- IMMUNOSWITCH (2009, hostInstitution)
- DIGITAL SEQUENCING (2009, participant)
- BRAINTRAIN (2009, participant)
- EUROHOPE (2010, participant)
- EVIMALAR (2009, participant)
- NOPERSIST (2010, participant)
- CHAARM (2010, participant)
- TRANSFoRm (2010, participant)
- COPHES (2009, participant)
- ANGIOFAT (2010, hostInstitution)
- ANGIOFAT (2010, hostInstitution)
- TRANSPHORM (2010, participant)
- PREVENTRA (2010, hostInstitution)
- PREVENTRA (2010, hostInstitution)
- FUNCFOOD (2010, participant)
- AFFINOMICS (2010, participant)
- CAGEKID (2010, participant)
- PREHDICT (2010, participant)
- EURATRANS (2010, participant)
- PHOSCHEMREC (2010, participant)
- 3MICRON (2010, participant)
- SYNSYS (2010, participant)
- GAMETE RECOGNITION (2011, hostInstitution)
- GAMETE RECOGNITION (2011, hostInstitution)
- IMMEEDIA (2010, participant)
- EIMID ITN (2010, participant)
- BRAINCELL (2010, hostInstitution)
- BRAINCELL (2010, hostInstitution)
- GUMS AND JOINTS (2010, participant)
- TINN2 (2011, participant)
- VIVAC (2010, participant)
- MEDALL (2010, participant)
- BIOSHARE-EU (2010, participant)
- TREATPOLYQ (2011, participant)
- SPECIAL (2010, participant)
- ICRES (2010, participant)
- EUPRIM-NET II (2011, participant)
- EPI-CT (2011, participant)
- ENDOSWITCH (2011, hostInstitution)
- ENDOSWITCH (2011, hostInstitution)
- MITOCARE (2011, participant)
- GLYCOHIT (2011, participant)
- EPC-TM-NET (2011, participant)
- EPICE (2011, participant)
- EUROCOORD (2011, participant)
- PEVNET (2011, participant)
- CHEPSAA (2011, participant)
- ETATMBA (2011, participant)
- SCR&TOX (2011, participant)
- NOTOX (2011, participant)
- TOXBANK (2011, participant)
- HIVEVO (2011, beneficiary)
- AirPROM (2011, participant)
- GENECADD (2011, hostInstitution)
- GENECADD (2011, hostInstitution)
- MAARS (2011, participant)
- ENCCA (2011, participant)
- ARTFORCE (2011, participant)
- IDEAL (2011, participant)
- HUFATREG (2011, hostInstitution)
- HUFATREG (2011, hostInstitution)
- NU-AGE (2011, participant)
- ECNIS2 (2011, participant)
- SYNERGY-COPD (2011, participant)
- HBP (2011, participant)
- NEURAL RENEWAL (2011, hostInstitution)
- NEURAL RENEWAL (2011, hostInstitution)
- NEURONSINMOTION (2011, hostInstitution)
- NEURONSINMOTION (2011, hostInstitution)
- N4U (2011, participant)